BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 18201269)

  • 1. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
    Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
    Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
    Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
    Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
    Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
    Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
    Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
    J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.
    Geraldo MV; Nakaya HI; Kimura ET
    Oncotarget; 2017 Feb; 8(6):9597-9607. PubMed ID: 28030816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
    Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
    Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.
    Wen Q; Zhao J; Bai L; Wang T; Zhang H; Ma Q
    Oncol Rep; 2015 Oct; 34(4):2202-10. PubMed ID: 26239517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC).
    Jazdzewski K; Boguslawska J; Jendrzejewski J; Liyanarachchi S; Pachucki J; Wardyn KA; Nauman A; de la Chapelle A
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E546-53. PubMed ID: 21159845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA expression may account for chronic but not for acute regulation of mRNA expression in human thyroid tumor models.
    Floor SL; Hebrant A; Pita JM; Saiselet M; Trésallet C; Libert F; Andry G; Dumont JE; van Staveren WC; Maenhaut C
    PLoS One; 2014; 9(11):e111581. PubMed ID: 25375362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
    Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
    Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
    Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
    Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.
    Capezzone M; Cantara S; Marchisotta S; Filetti S; De Santi MM; Rossi B; Ronga G; Durante C; Pacini F
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3950-7. PubMed ID: 18664542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
    Liu L; Wang J; Li X; Ma J; Shi C; Zhu H; Xi Q; Zhang J; Zhao X; Gu M
    Biochem Biophys Res Commun; 2015 Feb; 457(4):621-6. PubMed ID: 25603050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a.
    Pacifico F; Crescenzi E; Mellone S; Iannetti A; Porrino N; Liguoro D; Moscato F; Grieco M; Formisano S; Leonardi A
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1421-30. PubMed ID: 20061417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
    Wang Z; Zhang H; Zhang P; Dong W; He L
    Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.
    Orlandella FM; Di Maro G; Ugolini C; Basolo F; Salvatore G
    Oncotarget; 2016 Oct; 7(43):70575-70588. PubMed ID: 27661106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA expression in anaplastic thyroid carcinomas.
    Hébrant A; Floor S; Saiselet M; Antoniou A; Desbuleux A; Snyers B; La C; de Saint Aubain N; Leteurtre E; Andry G; Maenhaut C
    PLoS One; 2014; 9(8):e103871. PubMed ID: 25153510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.
    Lv M; Zhang X; Li M; Chen Q; Ye M; Liang W; Ding L; Cai H; Fu D; Lv Z
    PLoS One; 2013; 8(7):e67591. PubMed ID: 23861775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.